McLaren Bernadette K, Schuyler Peggy A, Sanders Melinda E, Jensen Roy A, Simpson Jean F, Dupont William D, Page David L
Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2561, USA.
Cancer. 2006 Sep 15;107(6):1227-33. doi: 10.1002/cncr.22113.
Atypical lobular hyperplasia (ALH) is associated with a 10% to 20% risk of subsequent invasive carcinoma, primarily in the ipsilateral breast. Nottingham grading, special tumor types, and survival after invasive cancer diagnosis were analyzed consistently for the first time.
A longitudinal follow-up study of 252 women who underwent 261 benign surgical biopsies between 1950 and 1985 with a diagnosis of ALH was undertaken. Subsequent invasive breast cancers were graded and subtyped based on histologic features and the cohort assessed for cancer survival.
Forty-eight (19%) women developed invasive breast cancer at an average of 15.1 years. Twenty (42%) of the tumors were special subtype tumors with good prognosis. By an average of 13 years after invasive cancer diagnosis, 2 (10%) of 20 women with special type and variant tumors had died of breast cancer, compared with 9 (32%) of 28 women with tumors of no special type (24 tumors) or an unknown type (4 tumors). Only 1 patient with a tumor of low Nottingham grade died of breast cancer.
ALH is a nonobligate cancer precursor associated with a moderate risk of breast cancer and predicts that later cancers are associated with overall excellent survival. Nearly half of the subsequent cancers show classic or variant patterns of special types with a good prognosis and the majority are of low or intermediate combined histologic grade. Treatment of women with ALH should be influenced by their modest elevation in breast cancer risk and the good prognosis and low mortality of many of these cancers.
非典型小叶增生(ALH)与随后发生浸润性癌的风险为10%至20%相关,主要发生在同侧乳房。首次对诺丁汉分级、特殊肿瘤类型以及浸润性癌诊断后的生存率进行了连贯分析。
对1950年至1985年间接受261次良性手术活检且诊断为ALH的252名女性进行了纵向随访研究。根据组织学特征对随后发生的浸润性乳腺癌进行分级和亚型分类,并评估该队列的癌症生存率。
48名(19%)女性发生了浸润性乳腺癌,平均时间为15.1年。其中20例(42%)肿瘤为预后良好的特殊亚型肿瘤。浸润性癌诊断后平均13年,20例特殊类型和变异型肿瘤患者中有2例(10%)死于乳腺癌,而28例非特殊类型(24例肿瘤)或未知类型(4例肿瘤)患者中有9例(32%)死于乳腺癌。只有1例诺丁汉分级低的肿瘤患者死于乳腺癌。
ALH是一种非必然的癌症前体,与乳腺癌的中度风险相关,并预示着后期癌症的总体生存率良好。近一半的后续癌症表现为预后良好的特殊类型的经典或变异模式,且大多数为低或中度联合组织学分级。对ALH女性的治疗应受其乳腺癌风险适度升高以及许多此类癌症预后良好和死亡率低的影响。